Association Between Carotid Atherosclerosis and Atrial Fibrillation, Cardiac, and Renal Function

David Leander Rimmele1, Katrin Borof2, Märit Jensen1

  • 1Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Insights

Carotid atherosclerosis (CA) is linked to heart dysfunction markers, but not renal function, independent of common risk factors. Carotid ultrasound aids in assessing cardiovascular risk by identifying cardiac dysfunction.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Nephrology

Background:

  • Carotid atherosclerosis (CA) is a significant indicator of cardiovascular risk.
  • Understanding the interplay between CA, atrial fibrillation (AF), heart function, and renal function is crucial for risk stratification.
  • Traditional risk factors may mediate these associations, necessitating further investigation.

Purpose of the Study:

  • To investigate whether traditional risk factors mediate the association between carotid atherosclerosis (CA) and atrial fibrillation (AF), heart function, and renal function.
  • To determine the independent associations of CA with AF, NT-proBNP, and eGFR.
  • To evaluate the utility of carotid ultrasound in assessing cardiovascular risk profiles.

Main Methods:

  • Cross-sectional analysis of the first cohort from the population-based Hamburg City Health Study (n=9,466, aged 45-74).
  • Carotid ultrasound assessed CA (CIMT ≥ 1 mm or plaques).
  • NT-proBNP and eGFR measured heart and renal function, respectively. Multivariable regression analyzed associations.

Main Results:

  • CA was present in 34% of participants.
  • Individuals with CA showed higher prevalence of AF (9.6% vs 4.3%), elevated NT-proBNP (100 vs 73 pg/mL), and lower eGFR (82.8 vs 87.1 mL/min).
  • CA remained independently associated with NT-proBNP but not eGFR after adjusting for risk factors. The association with AF was not independent of NT-proBNP.

Conclusions:

  • Carotid atherosclerosis is independently associated with markers of cardiac dysfunction (NT-proBNP), mediated through common risk factors and NT-proBNP itself.
  • The association between CA and AF appears to be mediated by NT-proBNP levels.
  • CA is not associated with renal function (eGFR) independent of other factors. Carotid ultrasound is valuable for cardiovascular risk assessment.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
163
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
71
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
543
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
130
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
179